Struma ovarii screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 2: | Line 2: | ||
{{Struma ovarii}} | {{Struma ovarii}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{ARK}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for Struma ovarii. | There is insufficient evidence to recommend routine screening for Struma ovarii. |
Revision as of 13:50, 21 August 2017
Struma ovarii Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Struma ovarii screening On the Web |
American Roentgen Ray Society Images of Struma ovarii screening |
Risk calculators and risk factors for Struma ovarii screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
There is insufficient evidence to recommend routine screening for Struma ovarii.
Screening
- There is insufficient evidence to recommend routine screening for Struma ovarii.
- For follow-up as a marker of recurrence, serum thyroglobulin levels and I131 scan may be used. [1] [2]
- The I131 scan or thyroglobulin have no aid in the follow-up if thyroidectomy is not performed. [3]
- In cases of metastatic struma ovarii post total thyroidectomy along with radioiodine scanning and radioiodine ablation, the thyroglobulin levels must be monitored as a tumor marker, and diagnostic radioiodine scans should be done to screen for residual or recurrent disease. [4]
References
- ↑ Volpi E, Ferrero A, Nasi PG, Sismondi P (2003). "Malignant struma ovarii: a case report of laparoscopic management". Gynecol. Oncol. 90 (1): 191–4. PMID 12821363.
- ↑ Zekri JM, Manifold IH, Wadsley JC (2006). "Metastatic struma ovarii: late presentation, unusual features and multiple radioactive iodine treatments". Clin Oncol (R Coll Radiol). 18 (10): 768–72. PMID 17168212.
- ↑ Balci TA, Kabasakal L (2005). "Is the I-131 whole-body scanning proper for follow-up management of the patients with malignant struma ovarii without performing the thyroidectomy?". Gynecol. Oncol. 99 (2): 520. doi:10.1016/j.ygyno.2005.04.017. PMID 15963556.
- ↑ McGill JF, Sturgeon C, Angelos P (2009). "Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation". Endocr Pract. 15 (2): 167–73. doi:10.4158/EP.15.2.167. PMID 19289330.